3.99
Schlusskurs vom Vortag:
$4.10
Offen:
$4.11
24-Stunden-Volumen:
971.51K
Relative Volume:
0.64
Marktkapitalisierung:
$252.61M
Einnahmen:
$231.67M
Nettoeinkommen (Verlust:
$-42.43M
KGV:
-2.5638
EPS:
-1.5563
Netto-Cashflow:
$-26.29M
1W Leistung:
-11.14%
1M Leistung:
+4.18%
6M Leistung:
+10.53%
1J Leistung:
-24.57%
Aurora Cannabis Inc Stock (ACB) Company Profile
Compare ACB vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ACB
Aurora Cannabis Inc
|
3.99 | 252.61M | 231.67M | -42.43M | -26.29M | -1.5563 |
|
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Aurora Cannabis Inc Stock (ACB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-11 | Eingeleitet | TD Cowen | Buy |
| 2024-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-09-21 | Hochstufung | Canaccord Genuity | Sell → Hold |
| 2022-06-24 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2022-06-06 | Hochstufung | Stifel | Sell → Hold |
| 2021-09-28 | Hochstufung | MKM Partners | Sell → Neutral |
| 2021-09-03 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-05-14 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-05-14 | Herabstufung | Canaccord Genuity | Hold → Sell |
| 2021-05-11 | Herabstufung | CIBC | Neutral → Sector Underperform |
| 2021-04-28 | Fortgesetzt | BofA Securities | Neutral |
| 2021-02-12 | Herabstufung | Desjardins | Hold → Sell |
| 2021-02-12 | Herabstufung | MKM Partners | Neutral → Sell |
| 2021-02-12 | Herabstufung | Needham | Hold → Underperform |
| 2020-12-18 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2020-11-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-11-11 | Herabstufung | Stifel | Hold → Sell |
| 2020-10-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-21 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-24 | Hochstufung | Stifel | Sell → Hold |
| 2020-05-22 | Herabstufung | Jefferies | Hold → Underperform |
| 2020-05-15 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2020-02-27 | Herabstufung | Bryan Garnier | Neutral → Sell |
| 2020-02-25 | Eingeleitet | Needham | Hold |
| 2020-02-24 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-14 | Hochstufung | MKM Partners | Sell → Neutral |
| 2020-02-07 | Herabstufung | Canaccord Genuity | Speculative Buy → Hold |
| 2020-01-10 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-10 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-12-23 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-15 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-11-05 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2019-09-24 | Eingeleitet | CIBC | Neutral |
Alle ansehen
Aurora Cannabis Inc Aktie (ACB) Neueste Nachrichten
Aurora Cannabis Inc - Baystreet.ca
Stocks in play: Aurora Cannabis Inc - Yahoo! Finance Canada
An offer runs to December 4, 2026, as Aurora Cannabis (ACB) explores other potential deals. - Stock Titan
3 Huge Red Flags From Tilray's Q1 Earnings Report - The Motley Fool
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway - Cantech Letter
Curaleaf Files Update to Offering Circular - Cannabis Business Times
Curaleaf Files Update to Offering Circular - Morningstar
A $5-per-share offer would pair $1 cash with Curaleaf shares for Aurora holders - Stock Titan
Shareholders get more time as Curaleaf revises its bid for Aurora Cannabis (ACB). - Stock Titan
Aurora Maintains Shareholder Recommendation to Take No Action; Curaleaf Has Yet to File Revised Bid - Cannabis Business Times
Aurora Urges Shareholders to Take No Action to Revised Hostile Bid by Curaleaf as Formal Review Underway - PR Newswire
Curaleaf Enhances Offer to Acquire Aurora Cannabis in Takeover Bid - Cannabis Business Times
Curaleaf Increases Takeover Offer for Aurora Cannabis to US$5 per Share - StratCann
Curaleaf enhances offer to acquire Aurora Cannabis (CURLF:OTCMKTS) - Seeking Alpha
Curaleaf Enhances Offer to Acquire Aurora Cannabis - Morningstar
Curaleaf Enhances Offer to Acquire Aurora Cannabis - Yahoo! Finance Canada
Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch. - The Motley Fool
Aurora Cannabis shareholders back board re-election and pay plan - scanx.trade
Aurora Cannabis Inc.Common Shares (NQ: ACB - The Chronicle-Journal
Aurora Cannabis Inc. - Baystreet.ca
Curaleaf Sends Letter to Aurora Shareholders - Cannabis Business Times
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid - TradingView
Curaleaf Sends Letter to Aurora Shareholders - Morningstar
Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid - The Globe and Mail
Aurora Cannabis and the Changing Cannabis Landscape - Kalkine Media
Why Is Aurora Cannabis (TSX:ACB) Trending Today? - Kalkine Media
TLRY Stock Loses 17% in Three Months: Should You Buy, Hold or Sell? - The Globe and Mail
StockTalk | Cannabis Report: M&A sparks, insider buys and revenue highs | 2026-09-11 | Investing News - Stockhouse
Aurora Cannabis (NASDAQ:ACB) faces a fresh market test as oil and yields rise - Kalkine Media
What Curaleaf’s hostile takeover bid for Aurora Cannabis is really about - MJBizDaily
Aurora Cannabis Inc. stock falls Thursday, underperforms market - MarketWatch
Why Is Aurora Cannabis (NASDAQ:ACB) Back in Focus? - Kalkine Media
Stocks in play: Aurora Cannabis Inc. - The Globe and Mail
Aurora Cannabis Inc. Announces Appointment of Faris El Refaie as Executive Vice President, Global Commercial, Effective September 28, 2026 - marketscreener.com
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business - The Globe and Mail
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business - PR Newswire
Aurora Names Faris El Refaie EVP, Global Commercial - mg Magazine
What Is Shaping Interest in Aurora Cannabis Stock? (NASDAQ:ACB) - Kalkine Media
Aurora Cannabis Inc. stock falls Tuesday, underperforms market - MarketWatch
Curaleaf Issues Fact Sheet to Address What It Believes Are Misleading Statements From Aurora - cannabisbusinesstimes.com
Curaleaf issues fact sheet defending bid to buy Aurora Cannabis - Bitget
Curaleaf Accuses Aurora of Misleading Shareholders in New "Fact Sheet" - StratCann
What Should Canadians Know About Aurora Cannabis Inc. (TSX:ACB)? - Kalkine Media
Curaleaf Issues Fact Sheet to Address What It Believes Are Misleading Statements From Aurora - Morningstar
Why Aurora Cannabis Inc. (ACB) Is Trending on the TSX Right Now - kalkine.ca
Curaleaf & Aurora’s Takeover Battle: Votes, Valuations and Vitriol - Business of Cannabis
Why Is Aurora Cannabis Inc (TSX:ACB) Turning Heads In Cannabis Stocks? - Kalkine Media
Aurora Cannabis Inc. (ACB): The Canadian Health Stock Investors May Want on Their Radar - kalkine.ca
Should You Buy Canopy Growth Stock on the Rebound? - The Motley Fool
Aurora Cannabis (TSX:ACB): What Factors Are Shaping Shares? - Kalkine Media
Finanzdaten der Aurora Cannabis Inc-Aktie (ACB)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):